Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Lintuzumab> ?p ?o }
Showing triples 1 to 72 of
72
with 100 triples per page.
- Lintuzumab abstract "Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML), a condition which results in the deaths of 9,000 people a year in the United States. Lintuzumab targets the CD33 protein, which is expressed in AML and other myeloproliferative diseases, but does not appear in abundance on normal cells.Trials for AML were abandoned in 2010 when a phase IIb trial failed to show increased survival.As of 2010, Seattle Genetics was conducting Phase II trials of lintuzumab in conjunction with bortezomib (marketed as Velcade) as a treatment for those with myelodysplastic syndromes.".
- Lintuzumab atcPrefix "none".
- Lintuzumab casNumber "166089-32-3".
- Lintuzumab wikiPageID "9685873".
- Lintuzumab wikiPageLength "5560".
- Lintuzumab wikiPageOutDegree "26".
- Lintuzumab wikiPageRevisionID "669873119".
- Lintuzumab wikiPageWikiLink Acute_leukemia.
- Lintuzumab wikiPageWikiLink Acute_myeloid_leukemia.
- Lintuzumab wikiPageWikiLink Blood_transfusion.
- Lintuzumab wikiPageWikiLink Bone_marrow.
- Lintuzumab wikiPageWikiLink Bortezomib.
- Lintuzumab wikiPageWikiLink CD33.
- Lintuzumab wikiPageWikiLink Cancer.
- Lintuzumab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Lintuzumab wikiPageWikiLink Category:Orphan_drugs.
- Lintuzumab wikiPageWikiLink Chemotherapy.
- Lintuzumab wikiPageWikiLink Clinical_trial.
- Lintuzumab wikiPageWikiLink Clofarabine.
- Lintuzumab wikiPageWikiLink Cytarabine.
- Lintuzumab wikiPageWikiLink European_Medicines_Agency.
- Lintuzumab wikiPageWikiLink Food_and_Drug_Administration.
- Lintuzumab wikiPageWikiLink Gemtuzumab_ozogamicin.
- Lintuzumab wikiPageWikiLink Genzyme.
- Lintuzumab wikiPageWikiLink Humanized_antibody.
- Lintuzumab wikiPageWikiLink Humanized_monoclonal_antibody.
- Lintuzumab wikiPageWikiLink Myelodysplastic_syndrome.
- Lintuzumab wikiPageWikiLink Myeloproliferative_disease.
- Lintuzumab wikiPageWikiLink Myeloproliferative_neoplasm.
- Lintuzumab wikiPageWikiLink Orphan_drug.
- Lintuzumab wikiPageWikiLink PDL_BioPharma.
- Lintuzumab wikiPageWikiLink Pfizer.
- Lintuzumab wikiPageWikiLink Placebo.
- Lintuzumab wikiPageWikiLink Seattle_Genetics.
- Lintuzumab wikiPageWikiLinkText "Lintuzumab".
- Lintuzumab wikiPageWikiLinkText "lintuzumab".
- Lintuzumab atcPrefix "none".
- Lintuzumab casNumber "166089".
- Lintuzumab chemspiderid "NA".
- Lintuzumab hasPhotoCollection Lintuzumab.
- Lintuzumab mabType "mab".
- Lintuzumab source "zu/o".
- Lintuzumab target CD33.
- Lintuzumab type "mab".
- Lintuzumab verifiedfields "changed".
- Lintuzumab verifiedrevid "458270010".
- Lintuzumab wikiPageUsesTemplate Template:Citation.
- Lintuzumab wikiPageUsesTemplate Template:Drugbox.
- Lintuzumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Lintuzumab wikiPageUsesTemplate Template:Reflist.
- Lintuzumab subject Category:Monoclonal_antibodies_for_tumors.
- Lintuzumab subject Category:Orphan_drugs.
- Lintuzumab hypernym Antibody.
- Lintuzumab type Article.
- Lintuzumab type ChemicalSubstance.
- Lintuzumab type Drug.
- Lintuzumab type Antibody.
- Lintuzumab type Article.
- Lintuzumab type Chemical.
- Lintuzumab type Drug.
- Lintuzumab type ChemicalObject.
- Lintuzumab type Thing.
- Lintuzumab type Q8386.
- Lintuzumab comment "Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML), a condition which results in the deaths of 9,000 people a year in the United States.".
- Lintuzumab label "Lintuzumab".
- Lintuzumab sameAs لينتوزوماب.
- Lintuzumab sameAs Lintuzumab.
- Lintuzumab sameAs m.02pp2_f.
- Lintuzumab sameAs Q3833129.
- Lintuzumab sameAs Q3833129.
- Lintuzumab wasDerivedFrom Lintuzumab?oldid=669873119.
- Lintuzumab isPrimaryTopicOf Lintuzumab.